Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01269710 · ClinicalTrials.gov registry record
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 4
- Enrollment target
NCT01269710 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 4 participants.
The verdict
NCT01269710 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to get a better understanding of the side effect burden and identify predictors of psychotic, mood and aggressive disorders in children and adolescents. The study's primary aim is to identify genetic risk factors for weight gain and metabolic abnormalities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01269710
The ClinicalTrials.gov registry entry for NCT01269710 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01269710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01269710 about?
NCT01269710 is a clinical study titled "Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study". The purpose of this study is to get a better understanding of the side effect burden and identify predictors of psychotic, mood and aggressive disorders in children and adolescents. The study's primary aim is to identify genetic risk factors for weight gain and metabolic abnormalities.
What is the current status of trial NCT01269710?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2009-10. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT01269710?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.